159 related articles for article (PubMed ID: 10688849)
1. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation.
Kushida T; Inaba M; Takeuchi K; Sugiura K; Ogawa R; Ikehara S
Blood; 2000 Mar; 95(5):1862-8. PubMed ID: 10688849
[TBL] [Abstract][Full Text] [Related]
2. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice.
Kushida T; Inaba M; Hisha H; Ichioka N; Esumi T; Ogawa R; Iida H; Ikehara S
Blood; 2001 May; 97(10):3292-9. PubMed ID: 11342461
[TBL] [Abstract][Full Text] [Related]
3. A new strategy for treatment of autoimmune diseases in chimeric resistant MRL/lpr mice.
Takeuchi K; Inaba M; Miyashima S; Ogawa R; Ikehara S
Blood; 1998 Jun; 91(12):4616-23. PubMed ID: 9616158
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation: a new strategy for intractable diseases.
Ikehara S
Drugs Today (Barc); 2002 Feb; 38(2):103-11. PubMed ID: 12532188
[TBL] [Abstract][Full Text] [Related]
5. Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation.
Hosaka N; Ryu T; Miyake T; Cui W; Nishida T; Takaki T; Inaba M; Ikehara S
Clin Exp Immunol; 2007 Mar; 147(3):555-63. PubMed ID: 17302907
[TBL] [Abstract][Full Text] [Related]
6. New strategies for BMT, organ transplantation, and regeneration therapy.
Ikehara S
Hematology; 2003 Apr; 8(2):77-81. PubMed ID: 12745656
[TBL] [Abstract][Full Text] [Related]
7. Crucial role of donor-derived stromal cells in successful treatment for intractable autoimmune diseases in mrl/lpr mice by bmt via portal vein.
Kushida T; Inaba M; Hisha H; Ichioka N; Esumi T; Ogawa R; Iida H; Ikehara S
Stem Cells; 2001; 19(3):226-35. PubMed ID: 11359948
[TBL] [Abstract][Full Text] [Related]
8. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation.
Ikehara S; Yasumizu R; Inaba M; Izui S; Hayakawa K; Sekita K; Toki J; Sugiura K; Iwai H; Nakamura T
Proc Natl Acad Sci U S A; 1989 May; 86(9):3306-10. PubMed ID: 2654943
[TBL] [Abstract][Full Text] [Related]
9. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor.
Ishida T; Inaba M; Hisha H; Sugiura K; Adachi Y; Nagata N; Ogawa R; Good RA; Ikehara S
J Immunol; 1994 Mar; 152(6):3119-27. PubMed ID: 8144907
[TBL] [Abstract][Full Text] [Related]
10. Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice.
Cui YZ; Hisha H; Yang GX; Fan TX; Jin T; Li Q; Lian Z; Ikehara S
Bone Marrow Transplant; 2002 Dec; 30(12):843-9. PubMed ID: 12476275
[TBL] [Abstract][Full Text] [Related]
11. Analyses of acute graft-versus-host-like reaction in [MRL/lpr----MRL/+] chimeric mice using MRL/lpr-Thy-1. 1 congenic mice.
Nakagawa T; Nagata N; Hosaka N; Inaba M; Yasumizu R; Ogawa R; Ikehara S
Cell Immunol; 1991 Oct; 137(1):189-99. PubMed ID: 1679378
[TBL] [Abstract][Full Text] [Related]
12. Prevention of autoimmune hearing loss in MRL/lpr mice by bone marrow transplantation.
Lee S; Iwai H; Sugiura K; Takeuchi K; Kushida T; Tomoda K; Inaba M; Yamashita T; Ikehara S
Bone Marrow Transplant; 2000 Oct; 26(8):887-92. PubMed ID: 11081390
[TBL] [Abstract][Full Text] [Related]
13. Auto-MHC class II-reactive T cell line obtained from MRL/+ mice suffering from lpr-GVHD. II. Analyses of functional characteristics of T cell line by in vivo administration.
Nagata N; Nakagawa T; Hosaka N; Ikehara S
Immunobiology; 1992 Nov; 186(5):339-50. PubMed ID: 1286875
[TBL] [Abstract][Full Text] [Related]
14. Treatment of autoimmune diseases in mice by a new method for allogeneic bone marrow transplantation.
Ikehara S
Ther Apher Dial; 2003 Jun; 7(3):292-7. PubMed ID: 12924603
[TBL] [Abstract][Full Text] [Related]
15. Resistance to lymphoid engraftment in lpr recipients of normal bone marrow: characterization of chimeric stem cell, monocyte and peripheral lymphoid lineages.
Glaser RM; Marshak-Rothstein A
Eur J Immunol; 1990 Sep; 20(9):1917-25. PubMed ID: 2209698
[TBL] [Abstract][Full Text] [Related]
16. Presence of donor-derived thymic epithelial cells in [B6-->MRL/lpr] mice after allogeneic intra-bone marrow-bone marrow transplantation (IBM-BMT).
Takaki T; Hosaka N; Miyake T; Cui W; Nishida T; Inaba M; Ikehara S
J Autoimmun; 2008 Dec; 31(4):408-15. PubMed ID: 19022623
[TBL] [Abstract][Full Text] [Related]
17. Functional analyses of lpr gene in MRL/Mp-lpr/lpr mice. Role of lymph node stromal cells in lpr-lymphadenopathy.
Ohnishi-Inoue Y; Yasumizu R; Sugiura K; Nagata N; Fan H; Oyaizu N; Inaba M; Toki J; Ikehara S
Immunobiology; 1992 Nov; 186(5):449-65. PubMed ID: 1286883
[TBL] [Abstract][Full Text] [Related]
18. The characteristics of hematopoietic stem cells from autoimmune-prone mice and the role of neural cell adhesion molecules in abnormal proliferation of these cells in MRL/lpr mice.
Wang X; Hisha H; Cui W; Song C; Mizokami T; Okazaki S; Li Q; Feng W; Kato J; Jiang S; Fan H; Ikehara S
Haematologica; 2007 Mar; 92(3):300-7. PubMed ID: 17339178
[TBL] [Abstract][Full Text] [Related]
19. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
[TBL] [Abstract][Full Text] [Related]
20. Treatment of autoimmune diseases by hematopoietic stem cell transplantation.
Ikehara S
Exp Hematol; 2001 Jun; 29(6):661-9. PubMed ID: 11378260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
